Reformulated Drug Sends Users Elsewhere
A harder-to-abuse version of OxyContin released two years ago has pushed users to other drugs that mimic the effects of opiates, including heroin.
A harder-to-abuse version of OxyContin released two years ago has pushed users to other drugs that mimic the effects of opiates, including heroin.
The new version of the drug, which is more difficult to crush, chew and dissolve, has reduced the incidence of OxyContin abuse. But researchers at Washington University in St. Louis say it has “generated an unanticipated outcome” in pushing users toward other drugs, some of them more dangerous, suggesting the problem of addiction cannot be solved simply by making certain drugs unavailable.
“Abuse-deterrent formulations may not be the ‘magic bullets’ that many hoped they would be in solving the growing problem of opioid abuse,” the researchers wrote in the July 12 issue of the New England Journal of Medicine.
— Posted by Alexander Reed Kelly
Your support matters…MedPage Today:
The researchers found the percentage of patients using OxyContin as their drug of choice fell from 35.6% before the new formulation was introduced to 12.8% almost 2 years later (PRead more
Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
Health & Wellness
Current regulation of safer nicotine products like vapes is based on politics, not science. It’s costing lives.
Book Excerpt
Decades before it gripped communities across the United States, the roots of the opioid epidemic began with shifting ideas about palliative care among medical professionals.
Film
Laura Poitras sacks the Sacklers with an ode to activism.
She was in her 20s when the book chronicling her addiction and depression was published, igniting a debate that lasted for much of her life.
The pharmaceutical executives behind the opioid crisis could learn a thing or two from people in recovery from drug addiction.
Those with drug and mental health problems also are targets of a media and public obsessed with clickbait.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.